Key Insights
The global glucagon market, valued at $576.13 million in 2025, is projected to experience robust growth, driven by a compound annual growth rate (CAGR) of 6.03% from 2025 to 2033. This expansion is fueled by several key factors. Increasing prevalence of hypoglycemia, particularly among diabetic patients relying on insulin therapy, creates a significant demand for glucagon as a rapid-acting countermeasure. Advancements in glucagon delivery systems, such as pre-filled pens and auto-injectors, are enhancing patient convenience and compliance, thereby boosting market uptake. The growing awareness among healthcare professionals and patients regarding the life-saving potential of glucagon in managing severe hypoglycemic events further contributes to market growth. Furthermore, the expanding geriatric population, which is more susceptible to hypoglycemia, presents a significant opportunity for market expansion. However, challenges such as stringent regulatory approvals and the high cost of glucagon products could potentially restrain market growth to some extent.
Competitive intensity in the glucagon market is notable, with key players including Novo Nordisk A/S, Xeris Biopharma Holdings Inc, and Amphastar Pharmaceuticals Inc. These companies are continuously investing in research and development to improve product efficacy, safety, and convenience. Strategic partnerships, acquisitions, and geographical expansion are also key strategies being adopted to enhance market share and penetrate emerging markets. The market segmentation is likely diverse, encompassing various delivery systems (e.g., injection, pre-filled pens), formulations (e.g., liquid, powder), and applications (e.g., emergency treatment, prophylactic use). Future growth will depend heavily on continued innovation, improved accessibility, and successful marketing initiatives that raise patient and physician awareness of glucagon's critical role in managing hypoglycemia. The market's trajectory suggests considerable potential for growth throughout the forecast period.

Glucagon Market Report: 2019-2033 Forecast
This comprehensive report provides a detailed analysis of the Glucagon Market, offering invaluable insights for stakeholders across the pharmaceutical and healthcare industries. Covering the period from 2019 to 2033, with a focus on the forecast period of 2025-2033 (base year 2025, estimated year 2025), this report meticulously examines market dynamics, competitive landscapes, and future growth prospects.
Glucagon Market Market Structure & Competitive Landscape
The global glucagon market exhibits a moderately concentrated structure, with several key players holding significant market share. The Herfindahl-Hirschman Index (HHI) for 2024 is estimated at xx, indicating a moderately concentrated market. Innovation plays a crucial role, driven by the need for improved delivery systems (e.g., pre-filled pens, nasal sprays) and enhanced efficacy. Regulatory approvals and stringent safety standards significantly impact market entry and product lifecycle. Product substitutes, such as other hypoglycemic agents, exert competitive pressure.
The market is segmented by end-user (hospitals, clinics, home-care settings) and product type (liquid injection, powder for injection, nasal spray). Mergers and acquisitions (M&A) activity has been moderate in recent years, with xx major deals recorded between 2019 and 2024. These activities have primarily focused on expanding product portfolios and geographical reach.
- Market Concentration: Moderately concentrated, HHI (2024) estimated at xx.
- Innovation Drivers: Improved delivery systems, enhanced efficacy, extended shelf-life.
- Regulatory Impacts: Stringent safety and efficacy standards influence market entry and product approvals.
- Product Substitutes: Other hypoglycemic agents pose competitive pressure.
- End-User Segmentation: Hospitals, clinics, home-care settings.
- M&A Trends: Moderate activity, primarily focused on portfolio expansion and geographical reach.
Glucagon Market Market Trends & Opportunities
The global glucagon market is projected to experience significant growth, with a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This growth is fueled by several factors. The rising prevalence of diabetes, particularly type 1 diabetes, is a primary driver, as glucagon is a critical treatment for severe hypoglycemia. Technological advancements, such as the development of convenient pre-filled auto-injectors and nasal sprays, are enhancing patient compliance and market accessibility. Consumer preferences are shifting towards easy-to-use and readily available treatment options, further driving market expansion. Intense competitive activity, including product launches and strategic partnerships, is shaping the market landscape. The market penetration rate for glucagon is currently estimated at xx%, with significant untapped potential in developing regions.

Dominant Markets & Segments in Glucagon Market
North America currently holds the largest market share in the global glucagon market, driven by high diabetes prevalence, well-established healthcare infrastructure, and robust regulatory frameworks. Within North America, the United States is the leading market. Key growth drivers in this region include:
- High Prevalence of Diabetes: A large and growing diabetic population requiring glucagon treatment.
- Advanced Healthcare Infrastructure: Well-equipped hospitals and clinics facilitate wider access to glucagon.
- Favorable Regulatory Environment: Efficient approval processes for new glucagon formulations.
Other regions, including Europe and Asia-Pacific, are also experiencing notable growth, fueled by rising diabetes incidence and increased healthcare spending. However, challenges such as limited healthcare access and lower per capita income in some developing economies could hinder market expansion in these regions.
Glucagon Market Product Analysis
The glucagon market encompasses various formulations, including traditional injectable solutions, pre-filled auto-injectors, and novel nasal sprays. Recent technological advancements have focused on improving delivery systems for enhanced patient convenience and efficacy. Pre-filled auto-injectors offer improved usability, reducing administration errors and enabling self-administration. Nasal sprays provide a non-invasive and rapid administration route, addressing limitations of traditional injections. The market is witnessing increased competition among various formulations, with manufacturers focusing on differentiating their products through improved delivery mechanisms, enhanced stability, and extended shelf-life.
Key Drivers, Barriers & Challenges in Glucagon Market
Key Drivers:
- Rising prevalence of diabetes globally.
- Technological advancements leading to improved delivery systems (e.g., pre-filled pens, nasal sprays).
- Growing awareness among patients and healthcare professionals regarding glucagon’s importance.
- Increasing healthcare expenditure in developed and developing economies.
Challenges & Restraints:
- High cost of glucagon products, potentially limiting accessibility in some markets.
- Stringent regulatory requirements for approval of new glucagon formulations.
- Potential supply chain disruptions impacting product availability and pricing.
- Competition from other hypoglycemic agents.
Growth Drivers in the Glucagon Market Market
The glucagon market's growth is driven by technological advancements resulting in improved delivery systems like pre-filled auto-injectors and nasal sprays, enhancing patient convenience and compliance. The escalating global prevalence of diabetes is a significant driver, increasing demand for effective hypoglycemia treatment. Favorable regulatory approvals for new formulations further accelerate market expansion.
Challenges Impacting Glucagon Market Growth
High production costs, strict regulatory hurdles for new product approvals, and supply chain vulnerabilities pose considerable challenges. Competition from alternative hypoglycemic treatments and the potential for generic competition further restrain market growth.
Key Players Shaping the Glucagon Market Market
- Novo Nordisk A/S
- Xeris Biopharma Holdings Inc
- Amphastar Pharmaceuticals Inc
- Zealand Pharma A/S
- Fresenius SE & Co KGaA
- Taj Pharmaceuticals Limited
- ILS Inc
- United Biotech (P) Limited
- Arecor
- Avalon Pharma Private Limited
Significant Glucagon Market Industry Milestones
- June 2023: Amphastar Pharmaceuticals Inc. acquired BAQSIMI (nasal glucagon) from Eli Lilly and Company. This acquisition expanded Amphastar's product portfolio and enhanced its presence in the glucagon market.
- February 2024: Arecor Therapeutics PLC launched Ogluo, a glucagon pre-filled autoinjector pen in the Netherlands. This new formulation offers improved convenience and usability for patients.
Future Outlook for Glucagon Market Market
The glucagon market is poised for continued growth, driven by the persistent increase in diabetes prevalence globally, coupled with ongoing innovation in delivery systems and formulations. Strategic partnerships, geographical expansion into emerging markets, and the development of novel glucagon analogs present significant opportunities for growth and market expansion in the coming years.
Glucagon Market Segmentation
-
1. Route of Administration
- 1.1. Injection
- 1.2. Inhalation
-
2. Application
- 2.1. Hypoglycemia
- 2.2. Diagnostic Aid
-
3. Distribution Channel
- 3.1. Online
- 3.2. Offline
Glucagon Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
- 4. Rest of the World

Glucagon Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.03% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Burden of Diabetes; Reimbursement Offered on Glucagon Products
- 3.3. Market Restrains
- 3.3.1. Increasing Burden of Diabetes; Reimbursement Offered on Glucagon Products
- 3.4. Market Trends
- 3.4.1. Hypoglycemia Segment is Expected to Witness Significant Growth During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Glucagon Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Route of Administration
- 5.1.1. Injection
- 5.1.2. Inhalation
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Hypoglycemia
- 5.2.2. Diagnostic Aid
- 5.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.3.1. Online
- 5.3.2. Offline
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 5.1. Market Analysis, Insights and Forecast - by Route of Administration
- 6. North America Glucagon Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Route of Administration
- 6.1.1. Injection
- 6.1.2. Inhalation
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Hypoglycemia
- 6.2.2. Diagnostic Aid
- 6.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 6.3.1. Online
- 6.3.2. Offline
- 6.1. Market Analysis, Insights and Forecast - by Route of Administration
- 7. Europe Glucagon Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Route of Administration
- 7.1.1. Injection
- 7.1.2. Inhalation
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Hypoglycemia
- 7.2.2. Diagnostic Aid
- 7.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 7.3.1. Online
- 7.3.2. Offline
- 7.1. Market Analysis, Insights and Forecast - by Route of Administration
- 8. Asia Pacific Glucagon Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Route of Administration
- 8.1.1. Injection
- 8.1.2. Inhalation
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Hypoglycemia
- 8.2.2. Diagnostic Aid
- 8.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 8.3.1. Online
- 8.3.2. Offline
- 8.1. Market Analysis, Insights and Forecast - by Route of Administration
- 9. Rest of the World Glucagon Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Route of Administration
- 9.1.1. Injection
- 9.1.2. Inhalation
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Hypoglycemia
- 9.2.2. Diagnostic Aid
- 9.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 9.3.1. Online
- 9.3.2. Offline
- 9.1. Market Analysis, Insights and Forecast - by Route of Administration
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis 2024
- 10.2. Company Profiles
- 10.2.1 Novo Nordisk A/S
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Xeris Biopharma Holdings Inc
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 Amphastar Pharmaceuticals Inc
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 Zealand Pharma A/S
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 Fresenius SE & Co KGaA
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 Taj Pharmaceuticals Limited
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 ILS Inc
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 United Biotech (P) Limited
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Arecor
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Avalon Pharma Private Limited*List Not Exhaustive
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.1 Novo Nordisk A/S
List of Figures
- Figure 1: Global Glucagon Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Glucagon Market Volume Breakdown (Million, %) by Region 2024 & 2032
- Figure 3: North America Glucagon Market Revenue (Million), by Route of Administration 2024 & 2032
- Figure 4: North America Glucagon Market Volume (Million), by Route of Administration 2024 & 2032
- Figure 5: North America Glucagon Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 6: North America Glucagon Market Volume Share (%), by Route of Administration 2024 & 2032
- Figure 7: North America Glucagon Market Revenue (Million), by Application 2024 & 2032
- Figure 8: North America Glucagon Market Volume (Million), by Application 2024 & 2032
- Figure 9: North America Glucagon Market Revenue Share (%), by Application 2024 & 2032
- Figure 10: North America Glucagon Market Volume Share (%), by Application 2024 & 2032
- Figure 11: North America Glucagon Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 12: North America Glucagon Market Volume (Million), by Distribution Channel 2024 & 2032
- Figure 13: North America Glucagon Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 14: North America Glucagon Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 15: North America Glucagon Market Revenue (Million), by Country 2024 & 2032
- Figure 16: North America Glucagon Market Volume (Million), by Country 2024 & 2032
- Figure 17: North America Glucagon Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: North America Glucagon Market Volume Share (%), by Country 2024 & 2032
- Figure 19: Europe Glucagon Market Revenue (Million), by Route of Administration 2024 & 2032
- Figure 20: Europe Glucagon Market Volume (Million), by Route of Administration 2024 & 2032
- Figure 21: Europe Glucagon Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 22: Europe Glucagon Market Volume Share (%), by Route of Administration 2024 & 2032
- Figure 23: Europe Glucagon Market Revenue (Million), by Application 2024 & 2032
- Figure 24: Europe Glucagon Market Volume (Million), by Application 2024 & 2032
- Figure 25: Europe Glucagon Market Revenue Share (%), by Application 2024 & 2032
- Figure 26: Europe Glucagon Market Volume Share (%), by Application 2024 & 2032
- Figure 27: Europe Glucagon Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 28: Europe Glucagon Market Volume (Million), by Distribution Channel 2024 & 2032
- Figure 29: Europe Glucagon Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 30: Europe Glucagon Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 31: Europe Glucagon Market Revenue (Million), by Country 2024 & 2032
- Figure 32: Europe Glucagon Market Volume (Million), by Country 2024 & 2032
- Figure 33: Europe Glucagon Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: Europe Glucagon Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Asia Pacific Glucagon Market Revenue (Million), by Route of Administration 2024 & 2032
- Figure 36: Asia Pacific Glucagon Market Volume (Million), by Route of Administration 2024 & 2032
- Figure 37: Asia Pacific Glucagon Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 38: Asia Pacific Glucagon Market Volume Share (%), by Route of Administration 2024 & 2032
- Figure 39: Asia Pacific Glucagon Market Revenue (Million), by Application 2024 & 2032
- Figure 40: Asia Pacific Glucagon Market Volume (Million), by Application 2024 & 2032
- Figure 41: Asia Pacific Glucagon Market Revenue Share (%), by Application 2024 & 2032
- Figure 42: Asia Pacific Glucagon Market Volume Share (%), by Application 2024 & 2032
- Figure 43: Asia Pacific Glucagon Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 44: Asia Pacific Glucagon Market Volume (Million), by Distribution Channel 2024 & 2032
- Figure 45: Asia Pacific Glucagon Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 46: Asia Pacific Glucagon Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 47: Asia Pacific Glucagon Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Asia Pacific Glucagon Market Volume (Million), by Country 2024 & 2032
- Figure 49: Asia Pacific Glucagon Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Asia Pacific Glucagon Market Volume Share (%), by Country 2024 & 2032
- Figure 51: Rest of the World Glucagon Market Revenue (Million), by Route of Administration 2024 & 2032
- Figure 52: Rest of the World Glucagon Market Volume (Million), by Route of Administration 2024 & 2032
- Figure 53: Rest of the World Glucagon Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 54: Rest of the World Glucagon Market Volume Share (%), by Route of Administration 2024 & 2032
- Figure 55: Rest of the World Glucagon Market Revenue (Million), by Application 2024 & 2032
- Figure 56: Rest of the World Glucagon Market Volume (Million), by Application 2024 & 2032
- Figure 57: Rest of the World Glucagon Market Revenue Share (%), by Application 2024 & 2032
- Figure 58: Rest of the World Glucagon Market Volume Share (%), by Application 2024 & 2032
- Figure 59: Rest of the World Glucagon Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 60: Rest of the World Glucagon Market Volume (Million), by Distribution Channel 2024 & 2032
- Figure 61: Rest of the World Glucagon Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 62: Rest of the World Glucagon Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 63: Rest of the World Glucagon Market Revenue (Million), by Country 2024 & 2032
- Figure 64: Rest of the World Glucagon Market Volume (Million), by Country 2024 & 2032
- Figure 65: Rest of the World Glucagon Market Revenue Share (%), by Country 2024 & 2032
- Figure 66: Rest of the World Glucagon Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Glucagon Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Glucagon Market Volume Million Forecast, by Region 2019 & 2032
- Table 3: Global Glucagon Market Revenue Million Forecast, by Route of Administration 2019 & 2032
- Table 4: Global Glucagon Market Volume Million Forecast, by Route of Administration 2019 & 2032
- Table 5: Global Glucagon Market Revenue Million Forecast, by Application 2019 & 2032
- Table 6: Global Glucagon Market Volume Million Forecast, by Application 2019 & 2032
- Table 7: Global Glucagon Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 8: Global Glucagon Market Volume Million Forecast, by Distribution Channel 2019 & 2032
- Table 9: Global Glucagon Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Global Glucagon Market Volume Million Forecast, by Region 2019 & 2032
- Table 11: Global Glucagon Market Revenue Million Forecast, by Route of Administration 2019 & 2032
- Table 12: Global Glucagon Market Volume Million Forecast, by Route of Administration 2019 & 2032
- Table 13: Global Glucagon Market Revenue Million Forecast, by Application 2019 & 2032
- Table 14: Global Glucagon Market Volume Million Forecast, by Application 2019 & 2032
- Table 15: Global Glucagon Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 16: Global Glucagon Market Volume Million Forecast, by Distribution Channel 2019 & 2032
- Table 17: Global Glucagon Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Glucagon Market Volume Million Forecast, by Country 2019 & 2032
- Table 19: United States Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United States Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 21: Canada Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Canada Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 23: Mexico Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Mexico Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 25: Global Glucagon Market Revenue Million Forecast, by Route of Administration 2019 & 2032
- Table 26: Global Glucagon Market Volume Million Forecast, by Route of Administration 2019 & 2032
- Table 27: Global Glucagon Market Revenue Million Forecast, by Application 2019 & 2032
- Table 28: Global Glucagon Market Volume Million Forecast, by Application 2019 & 2032
- Table 29: Global Glucagon Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 30: Global Glucagon Market Volume Million Forecast, by Distribution Channel 2019 & 2032
- Table 31: Global Glucagon Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Glucagon Market Volume Million Forecast, by Country 2019 & 2032
- Table 33: Germany Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Germany Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 35: United Kingdom Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: United Kingdom Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 37: France Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: France Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 39: Italy Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Italy Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 41: Spain Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Spain Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 43: Rest of Europe Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Europe Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 45: Global Glucagon Market Revenue Million Forecast, by Route of Administration 2019 & 2032
- Table 46: Global Glucagon Market Volume Million Forecast, by Route of Administration 2019 & 2032
- Table 47: Global Glucagon Market Revenue Million Forecast, by Application 2019 & 2032
- Table 48: Global Glucagon Market Volume Million Forecast, by Application 2019 & 2032
- Table 49: Global Glucagon Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 50: Global Glucagon Market Volume Million Forecast, by Distribution Channel 2019 & 2032
- Table 51: Global Glucagon Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Glucagon Market Volume Million Forecast, by Country 2019 & 2032
- Table 53: China Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: China Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 55: Japan Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Japan Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 57: India Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: India Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 59: Australia Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Australia Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 61: South Korea Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: South Korea Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 63: Rest of Asia Pacific Glucagon Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: Rest of Asia Pacific Glucagon Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 65: Global Glucagon Market Revenue Million Forecast, by Route of Administration 2019 & 2032
- Table 66: Global Glucagon Market Volume Million Forecast, by Route of Administration 2019 & 2032
- Table 67: Global Glucagon Market Revenue Million Forecast, by Application 2019 & 2032
- Table 68: Global Glucagon Market Volume Million Forecast, by Application 2019 & 2032
- Table 69: Global Glucagon Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 70: Global Glucagon Market Volume Million Forecast, by Distribution Channel 2019 & 2032
- Table 71: Global Glucagon Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Glucagon Market Volume Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Glucagon Market?
The projected CAGR is approximately 6.03%.
2. Which companies are prominent players in the Glucagon Market?
Key companies in the market include Novo Nordisk A/S, Xeris Biopharma Holdings Inc, Amphastar Pharmaceuticals Inc, Zealand Pharma A/S, Fresenius SE & Co KGaA, Taj Pharmaceuticals Limited, ILS Inc, United Biotech (P) Limited, Arecor, Avalon Pharma Private Limited*List Not Exhaustive.
3. What are the main segments of the Glucagon Market?
The market segments include Route of Administration, Application, Distribution Channel.
4. Can you provide details about the market size?
The market size is estimated to be USD 576.13 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Burden of Diabetes; Reimbursement Offered on Glucagon Products.
6. What are the notable trends driving market growth?
Hypoglycemia Segment is Expected to Witness Significant Growth During the Forecast Period.
7. Are there any restraints impacting market growth?
Increasing Burden of Diabetes; Reimbursement Offered on Glucagon Products.
8. Can you provide examples of recent developments in the market?
February 2024: Arecor Therapeutics PLC, through its subsidiary company, Tetris Pharma Ltd, launched Ogluo, a glucagon-prefilled autoinjector pen in the Netherlands. It is indicated to treat severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Glucagon Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Glucagon Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Glucagon Market?
To stay informed about further developments, trends, and reports in the Glucagon Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence